Activist investor Bluebell Capital Partners has built a stake in Bayer AG and is pushing for a breakup of the German pharmaceutical and agriculture company, Bloomberg reported on Tuesday, citing sources.
UK-based Bluebell is also seeking an overhaul of Bayer's corporate governance, the report added.
A Bayer spokesperson, who declined to comment on the report, said: "Generally speaking we are always open for a constructive dialogue with our stakeholders."
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.